Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors

The microbiome is now regarded as one of the hallmarks of cancer and several strategies to modify the gut microbiota to improve immune checkpoint inhibitor (ICI) activity are being evaluated in clinical trials. Preliminary data regarding the upper gastro-intestinal microbiota indicated that Helicoba...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine, Mihalcioiu, Catalin, Watson, Ian, Bouin, Mickael, Miller, Wilson, Hudson, Marie, Wong, Matthew K., Pezo, Rossanna C., Turcotte, Simon, Bélanger, Karl, Jamal, Rahima, Oster, Paul, Velin, Dominique, Richard, Corentin, Messaoudene, Meriem, Elkrief, Arielle, Routy, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272833/
https://www.ncbi.nlm.nih.gov/pubmed/35832043
http://dx.doi.org/10.1080/2162402X.2022.2096535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272833/
https://www.ncbi.nlm.nih.gov/pubmed/35832043
http://dx.doi.org/10.1080/2162402X.2022.2096535

Ejemplares similares